Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2012 /
Histology and non-histology driven therapy for soft tissue sarcomas and the Rare Cancers Europe initiative

28th Sep - 2nd Oct 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.10.12
Views: 6603

Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy

Dr Paolo Casali talks to ecancer at the 2012 ESMO meeting in Vienna about personalised medical therapy of soft tissue sarcomas.


This approach involves using histology and tailoring therapy based on each tumours genomics.


These complicated procedures require a lot analysis with molecular biology had increases problems in developing clinical trials.


Dr Casali also talks about the announcement of the launch of Rare Cancers Europe at ESMO 2012. This multidisciplinary initiative looks at the issues of creating clinical studies for rare cancers in order to quicken the development of drugs for clincial use.


Filming supported by Amgen

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation